C07D 285/08
1,2,4-thiadiazoles
Official title: 1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
C07D285/08 (1,2,4-thiadiazoles) appears on 484 US grants and 354 published applications in this corpus.
Search patents in C07D- Granted patents
- 484
- Published applications
- 354
- Assignees
- 275
- Inventors
- 1,513
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 5 | 0 |
| 1978 | 11 | 0 |
| 1979 | 9 | 0 |
| 1980 | 9 | 0 |
| 1981 | 6 | 0 |
| 1982 | 16 | 0 |
| 1983 | 9 | 0 |
| 1984 | 16 | 0 |
| 1985 | 12 | 0 |
| 1986 | 6 | 0 |
| 1987 | 9 | 0 |
| 1988 | 9 | 0 |
| 1989 | 7 | 0 |
| 1990 | 15 | 0 |
| 1991 | 8 | 0 |
| 1992 | 7 | 0 |
| 1993 | 8 | 0 |
| 1994 | 8 | 0 |
| 1995 | 9 | 0 |
| 1996 | 7 | 0 |
| 1997 | 5 | 0 |
| 1998 | 7 | 0 |
| 1999 | 11 | 0 |
| 2000 | 11 | 0 |
| 2001 | 10 | 3 |
| 2002 | 8 | 9 |
| 2003 | 8 | 15 |
| 2004 | 6 | 9 |
| 2005 | 5 | 14 |
| 2006 | 7 | 15 |
| 2007 | 7 | 14 |
| 2008 | 9 | 19 |
| 2009 | 7 | 15 |
| 2010 | 15 | 24 |
| 2011 | 14 | 14 |
| 2012 | 18 | 14 |
| 2013 | 12 | 14 |
| 2014 | 14 | 17 |
| 2015 | 14 | 12 |
| 2016 | 15 | 14 |
| 2017 | 14 | 23 |
| 2018 | 16 | 19 |
| 2019 | 17 | 12 |
| 2020 | 13 | 14 |
| 2021 | 7 | 10 |
| 2022 | 5 | 7 |
| 2023 | 5 | 16 |
| 2024 | 5 | 11 |
| 2025 | 4 | 9 |
| 2026 | 5 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Thiadiazolone derivatives and their use as AMPK agonists for the treatment of diabetes and related disorders2 Jun 2026US 12,643,918 B2Betagenon AB
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Inhibiting USP3631 Mar 2026US 12,590,087 B2Valo Health, Inc.
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Route for constructing chiral fragment of fezolinetant, intermediate thereof, and preparation method therefor24 Feb 2026US 12,559,484 B2Shenzhen Hwagen Pharmaceutical Co., Ltd.
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Bioactive Conjugate, Preparation Method Therefor and Use Thereof17 Sep 2026US 2026/0273080 A2BeOne Medicines I GmbH
- Err modulators17 Sep 2026US 2026/0274807 A1University of Health Sciences & Pharmacy in St. Louis
- N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels background6 Aug 2026US 2026/0226040 A1Merck Sharp & Dohme Corp.
- Linear heteroaryl diamide ire1/xbp1s activators9 Jul 2026US 2026/0193236 A1Protego Biopharma, Inc.
Most cited
By later US patents
- 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof66US 4,409,214 AFujisawa Pharmaceutical Co., Ltd. · 1983
- 1,2,4-Thiadiazolidine-3,5-dione63US 4,093,624 AICN Pharmaceuticals, Inc. · 1978
- Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides59US 6,080,767 AAventis Pharmaceuticals Products Inc. · 2000
- Carboxyalkenamidocephalosporins50US 4,634,697 AShionogi & Co., Ltd. · 1987
- Modulators of molecules with phosphotyrosine recognition units50US 5,972,978 ANovo Nordisk A/S · 1999